Peripheral Neuropathy
|
0.010 |
Biomarker
|
group |
BEFREE |
Sh3tc2-/- mice represent a well characterized disease model developing early onset progressive peripheral neuropathy with hypo- and demyelination, slowing of nerve conduction velocities and disturbed nodal architecture.
|
30907403 |
2019 |
Autistic Disorder
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
Characterization of a de novo translocation t(5;18)(q33.1;q12.1) in an autistic boy identifies a breakpoint close to SH3TC2, ADRB2, and HTR4 on 5q, and within the desmocollin gene cluster on 18q.
|
19086034 |
2009 |
Inflammatory neuropathy
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
One patient homozygous for the R954X mutation had a 20-year history of an inflammatory neuropathy that was superimposed onto the hereditary form, indicating that structural alterations to the SH3TC2 gene could possibly predispose to peripheral nerve inflammation.
|
19272779 |
2009 |
5q-syndrome
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
The commonly deleted region of the 5q- syndrome extends between the genes SH3TC2 (proximal boundary) and GLRA1 (distal boundary) and measures 2.9 Mb.
|
18508791 |
2008 |
Myelodysplastic Syndrome with Isolated del(5q)
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
The commonly deleted region of the 5q- syndrome extends between the genes SH3TC2 (proximal boundary) and GLRA1 (distal boundary) and measures 2.9 Mb.
|
18508791 |
2008 |
Chromosome 5, trisomy 5q
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
The commonly deleted region of the 5q- syndrome extends between the genes SH3TC2 (proximal boundary) and GLRA1 (distal boundary) and measures 2.9 Mb.
|
18508791 |
2008 |
Peripheral Nervous System Diseases
|
0.020 |
Biomarker
|
group |
BEFREE |
Sh3tc2-/- mice represent a well characterized disease model developing early onset progressive peripheral neuropathy with hypo- and demyelination, slowing of nerve conduction velocities and disturbed nodal architecture.
|
30907403 |
2019 |
Peripheral Nervous System Diseases
|
0.020 |
GeneticVariation
|
group |
BEFREE |
Charcot-Marie-Tooth disease type 4C (CMT4C) is one of the commonest autosomal recessive inherited peripheral neuropathies and is associated with mutations in the Rab11 effector, SH3TC2.
|
27068304 |
2016 |
Inherited neuropathies
|
0.040 |
Biomarker
|
disease |
BEFREE |
Subsequently, a series of validation projects were conducted based on 128 assessments of: 26 confirmed cases of inherited neuropathy (17 CMT1A, one CMT1B, one CMT1D, one CMT2C, one CMT2S, two CMT4C, one CMTX3, one Riboflavin Transporter Deficiency Type 2, and one unidentified mutation); seven 'at risk' cases and 95 unaffected healthy controls recruited through the NIH-funded Inherited Neuropathies Consortium.
|
30476010 |
2018 |
Inherited neuropathies
|
0.040 |
GeneticVariation
|
disease |
BEFREE |
In addition, next generation sequencing of 52 genes for hereditary neuropathies revealed a heterozygous missense mutation c.505T > C; p.Y169H in the SH3TC2 gene that was transmitted by the healthy father.
|
26794302 |
2016 |
Inherited neuropathies
|
0.040 |
GeneticVariation
|
disease |
BEFREE |
Mutations in the SH3TC2 gene are a frequent cause of demyelinating hereditary neuropathy among Czech patients.
|
21291453 |
2011 |
Inherited neuropathies
|
0.040 |
GeneticVariation
|
disease |
BEFREE |
Mutations in SH3TC2 (KIAA1985) cause Charcot-Marie-Tooth disease (CMT) type 4C, a demyelinating inherited neuropathy characterized by early-onset and scoliosis.
|
19744956 |
2009 |
Peripheral demyelinating neuropathy
|
0.050 |
GeneticVariation
|
disease |
BEFREE |
In conclusion, mutations in SH3TC2 are responsible for 26% of Greek patients with suspected CMT4, identifying CMT4C as the most common recessive demyelinating neuropathy in the Greek population, in accordance with other Mediterranean cohorts.
|
30653784 |
2019 |
Peripheral demyelinating neuropathy
|
0.050 |
Biomarker
|
disease |
BEFREE |
The SH3TC2 gene appeared to be the most frequently mutated gene for demyelinating neuropathy in this series by NGS.
|
31634715 |
2019 |
Peripheral demyelinating neuropathy
|
0.050 |
GeneticVariation
|
disease |
BEFREE |
Charcot-Marie-Tooth disease type 4C (CMT4C) is an autosomal recessive (AR) demyelinating neuropathy associated to SH3TC2 mutations, characterized by early onset, spine deformities, and cranial nerve involvement.
|
27231023 |
2016 |
Peripheral demyelinating neuropathy
|
0.050 |
Biomarker
|
disease |
BEFREE |
Our study therefore highlights the inherent evolutionary link between SH3TC2 and peripheral nerve myelination, pointing also towards a molecular mechanism underlying the specific demyelinating neuropathy that characterizes CMT4C.
|
27068304 |
2016 |
Peripheral demyelinating neuropathy
|
0.050 |
GeneticVariation
|
disease |
BEFREE |
Charcot-Marie-Tooth (CMT) neuropathy type 4C (CMT4C) is an autosomal recessive (AR), demyelinating neuropathy with early spine deformities caused by mutations in the SH3TC2 gene.
|
21291453 |
2011 |
Neuropathy
|
0.060 |
Biomarker
|
group |
BEFREE |
Charcot-Marie-Tooth type 4C (CMT4C) is an autosomal recessive dysmyelinating neuropathy characterized by precocious and rapidly progressive scoliosis.
|
25737037 |
2015 |
Neuropathy
|
0.060 |
GeneticVariation
|
group |
BEFREE |
Loss-of-function mutations in the Src homology 3 (SH3) domain and tetratricopeptide repeats 2 (SH3TC2) gene cause autosomal recessive demyelinating Charcot-Marie-Tooth neuropathy.
|
24833716 |
2014 |
Neuropathy
|
0.060 |
Biomarker
|
group |
BEFREE |
Charcot-Marie-Tooth (CMT) neuropathy type 4C (CMT4C) is an autosomal recessive (AR), demyelinating neuropathy with early spine deformities caused by mutations in the SH3TC2 gene.
|
21291453 |
2011 |
Neuropathy
|
0.060 |
GeneticVariation
|
group |
BEFREE |
Consistent with a function of Rab11 in Schwann cell myelination, SH3TC2 mutations that cause neuropathy disrupt the SH3TC2/Rab11 interaction, and forced expression of dominant negative Rab11 strongly impairs myelin formation in vitro.
|
20826437 |
2010 |
Neuropathy
|
0.060 |
Biomarker
|
group |
BEFREE |
The generated Sh3tc2 knockout mice thus present a reliable model of CMT4C neuropathy that was instrumental in establishing a role for Sh3tc2 in myelination and in the integrity of the node of Ranvier, a morphological phenotype that can be used as an additional CMT4C diagnostic marker.
|
19805030 |
2009 |
Neuropathy
|
0.060 |
GeneticVariation
|
group |
BEFREE |
We subsequently identified mutations in an uncharacterized transcript, KIAA1985, in 12 families with autosomal recessive neuropathy.
|
14574644 |
2003 |
Vital capacity
|
0.100 |
GeneticVariation
|
phenotype |
GWASCAT |
Leveraging Polygenic Functional Enrichment to Improve GWAS Power.
|
30595370 |
2019 |
Systolic Pressure
|
0.100 |
GeneticVariation
|
phenotype |
GWASCAT |
Leveraging Polygenic Functional Enrichment to Improve GWAS Power.
|
30595370 |
2019 |